Skip to main content
芭薇股份 logo

芭薇股份 — Investor Relations & Filings

Ticker · 920123 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 240 across all filing types
Latest filing 2024-08-27 Interim / Quarterly Rep…
Country CN China
Listing Beijing Stock Exchange 920123

About 芭薇股份

https://www.gzbawei.com/

Guangdong Bawei Biotechnology Corp., Ltd. is a comprehensive beauty and personal care solution provider specializing in research, development, production, and testing. The company offers integrated OEM, ODM, and OBM services, covering a wide range of product categories including skincare, hair care, body care, and makeup. Bawei is recognized for its commitment to scientific innovation, operating advanced R&D laboratories and an independent third-party testing center that ensures product safety and efficacy. By leveraging automated production lines and a rigorous quality management system, the company serves a diverse portfolio of domestic and international brands. Its core focus remains on delivering high-quality, customized formulations and manufacturing excellence to meet evolving consumer demands in the global beauty market.

Recent filings

Filing Released Lang Actions
2024年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled '半年度报告摘要 2024' which translates to '2024 Half-Year Report Summary'. It contains detailed financial data for the half-year period, including assets, liabilities, net profit, earnings per share, and other financial metrics. It also includes business descriptions, shareholder information, and notes on asset restrictions. The document length is 6367 characters, which is sufficient to contain substantive financial data and analysis. The content is consistent with a comprehensive interim or quarterly financial report rather than a brief announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). H1 2024
2024-08-27 Chinese
独立董事候选人声明与承诺（何红渠）
Board/Management Information Classification · 95% confidence The document is a statement and commitment by an independent director candidate (何红渠) for Guangdong Bawi Biotechnology Co., Ltd. It details the candidate's qualifications, independence criteria, and compliance with relevant laws and regulations. There are no financial statements, earnings data, or report attachments. The document is a formal declaration related to board/management information, specifically about a director candidate's qualifications and commitments. It is not an annual report, audit report, earnings release, or any other financial report. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is 2725 characters, which is relatively short and consistent with a declaration rather than a full report.
2024-08-15 Chinese
独立董事候选人声明与承诺（蔡光云）
Board/Management Information Classification · 100% confidence The document is a formal declaration and commitment statement by an independent director candidate (蔡光云) for Guangdong Bawi Biotechnology Co., Ltd. It details the candidate's qualifications, independence, and compliance with relevant laws and regulations for serving as an independent director. There are no financial statements, earnings data, or report attachments. The document is a regulatory announcement related to board/management information, specifically about a director candidate's declaration and commitment. Therefore, it fits best under Board/Management Information (MANG). The document length is short and does not contain financial data or report publication language, so it is not a report or announcement of a report.
2024-08-15 Chinese
关于拟修订《公司章程》公告
Governance Information Classification · 95% confidence The document is an announcement regarding the proposed amendments to the company's Articles of Association (公司章程), specifically changes to the board composition. It includes details about the revision content, reasons for the revision, and references to relevant laws and regulations. There is no financial data, no report attached or published, and no mention of voting results or executive changes beyond board structure amendments. This fits the category of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document length is short and focused on governance changes, not a full report or announcement of a report publication.
2024-08-15 Chinese
关于召开2024年第二次临时股东大会通知公告（提供网络投票）
AGM Information Classification · 95% confidence The document is a notice announcing the convening of the 2024 second extraordinary general meeting of shareholders (临时股东大会) for Guangdong Bawei Biotechnology Co., Ltd. It details the meeting date, voting methods, agenda items including board and supervisory committee elections, and procedural information. It does not contain actual financial statements or results, nor is it a transcript or report of the meeting outcomes. The document is an announcement of a shareholders meeting, specifically an extraordinary general meeting (EGM). According to the filing definitions, announcements about shareholder meetings and related materials fall under AGM Information (AGM-R) if they are about the meeting itself. Since this is a notice for a shareholders meeting (albeit an extraordinary one), the closest and most appropriate classification is AGM Information (AGM-R). The document length is under 5,000 characters and it is not a report publication announcement or regulatory filing. Therefore, the classification is AGM-R with high confidence.
2024-08-15 Chinese
独立董事提名人声明及承诺
Board/Management Information Classification · 95% confidence The document is a formal announcement from Guangdong Bawei Biotechnology Co., Ltd. nominating candidates for independent directors to the company's fourth board. It includes detailed statements and commitments regarding the qualifications, independence, and compliance of the nominees with relevant laws and regulations. There is no financial data, no report attached or referenced as published, and no indication of a meeting or voting results. The content focuses on board/management information specifically about director nominations. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is short (2725 characters), and it is not a report publication announcement or regulatory filing. Hence, the classification is MANG with high confidence.
2024-08-15 Chinese

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.